drugset / Trial / NCT01723501

Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth

NCT01723501

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Purpose of this study is determine if skin application of chlorhexidine at birth would reduce infection in infants weighing \<1500 g at birth.

Timeline

Start
2012-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 0.25 % Topical

Indications